Meiji Yasuda Life Insurance
WST icon

Meiji Yasuda Life Insurance’s West Pharmaceutical WST Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$820K Sell
2,283
-890
-28% -$272K 0.03% 156
2026
Q1 		$795K Buy
3,173
+1,472
+87% +$366K 0.03% 154
2025
Q4 		$468K Sell
1,701
-252
-13% -$68.9K 0.01% 192
2025
Q3 		$512K Buy
1,953
+362
+23% +$88K 0.01% 188
2025
Q2 		$348K Buy
+1,591
New +$340K 0.01% 207
2025
Q1 		– Sell
-1,270
Closed -$416K – 256
2024
Q4 		$416K Buy
+1,270
New +$400K 0.01% 210
2024
Q3 		– Sell
-659
Closed -$217K – 261
2024
Q2 		$217K Sell
659
-670
-50% -$237K ﹤0.01% 239
2024
Q1 		$526K Sell
1,329
-970
-42% -$359K 0.01% 215
2023
Q4 		$810K Buy
2,299
+1,020
+80% +$361K 0.02% 185
2023
Q3 		$480K Buy
1,279
+640
+100% +$248K 0.01% 214
2023
Q2 		$244K Buy
+639
New +$228K 0.01% 252
2022
Q3 		– Sell
-749
Closed -$226K – 309
2022
Q2 		$226K Hold
749
– – ﹤0.01% 279
2022
Q1 		$308K Sell
749
-289
-28% -$113K 0.01% 256
2021
Q4 		$487K Buy
1,038
+12
+1% +$5.17K 0.01% 230
2021
Q3 		$436K Sell
1,026
-100
-9% -$42.2K 0.01% 240
2021
Q2 		$404K Sell
1,126
-49
-4% -$16.2K 0.01% 249
2021
Q1 		$331K Sell
1,175
-720
-38% -$206K 0.01% 274
2020
Q4 		$537K Sell
1,895
-293
-13% -$82.2K 0.01% 196
2020
Q3 		$601K Buy
+2,188
New +$579K 0.01% 195

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Meiji Yasuda Life Insurance's WST Position: Q2 2026 in Review

Meiji Yasuda Life Insurance reduced its West Pharmaceutical (WST) stake by 28% in Q2 2026, selling an estimated $272K and leaving 2,283 shares worth $820K. The position accounts for 0.03% of the portfolio, ranked #156.

Meiji Yasuda Life Insurance first reported a position in WST in Q3 2020 and has held it in 19 quarters since. 835 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Meiji Yasuda Life Insurance held 2,283 shares of West Pharmaceutical worth $820K as of Q2 2026.
  • Meiji Yasuda Life Insurance sold 890 West Pharmaceutical shares in Q2 2026, an estimated $272K.
  • West Pharmaceutical made up 0.03% of Meiji Yasuda Life Insurance's portfolio in Q2 2026, its #156 holding.
  • Meiji Yasuda Life Insurance first reported a position in West Pharmaceutical in Q3 2020 and has held it in 19 quarters since.
  • 835 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.